Troubleshooting delays or other challenges is, unfortunately, common when using health insurance benefits. Many pulmonary hypertension (PH) medical teams have staff dedicated to navigating benefit denials, prior authorization requests and other potential delays. If you have questions or need to advocate for yourself, the Pulmonary Hypertension Association’s (PHA’s) resources can help.
To learn more, visit PHA’s Online Insurance Guide or contact PHA’s Treatment Access Program at 301-565-3004 x749. PHA is grateful to Actelion Pharmaceuticals U.S., Inc. and Gilead Sciences for their support of PHA’s Treatment Access Program throughout 2019.